Christopher J. Swank

Person

  • San Mateo, CA, US

Patents Grantslast 30 patents

  • Information Patent Grant

    SARS-COV2 main protease inhibitors

    • Patent number 12,091,420
    • Issue date Sep 17, 2024
    • Gilead Sciences, Inc.
    • Stephen E. Ammann
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Thienopyrrole compounds

    • Patent number 11,661,431
    • Issue date May 30, 2023
    • Gilead Sciences, Inc.
    • Stephen E. Ammann
    • C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

  • Information Patent Application

    SARS-COV2 MAIN PROTEASE INHIBITORS

    • Publication number 20240239807
    • Publication date Jul 18, 2024
    • GILEAD SCIENCES, INC.
    • Stephen E. Ammann
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    SARS-COV2 MAIN PROTEASE INHIBITORS

    • Publication number 20240116946
    • Publication date Apr 11, 2024
    • GILEAD SCIENCES, INC.
    • Stephen E. Ammann
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    THIENOPYRROLE COMPOUNDS

    • Publication number 20230365594
    • Publication date Nov 16, 2023
    • GILEAD SCIENCES, INC.
    • Stephen E. Ammann
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    THIENOPYRROLE COMPOUNDS

    • Publication number 20220389034
    • Publication date Dec 8, 2022
    • GILEAD SCIENCES, INC.
    • Stephen E. Ammann
    • C07 - ORGANIC CHEMISTRY